IDIQ for CDER GDUFA research program for brand name and/or generic pharmaceuticals to include small molecule and peptide therapeutics.
Forecast Overview
- NAICS
- 325412
- Performance end
- 8/2026
The Center for Drug Evaluation and Research (CDER), requires Pharmaceutical Manufacturer/Supplier to provide brand name and/or generic pharmaceuticals to include small molecule and peptide therapeutics. A Single award IDIQ contract is anticipated to provide multiple types of pharmaceutical drugs (approximately 75 types) to support the GDUFA research program.
Source
- Source
- HHS SBCX Forecast Export
- Source file
- Forecast.csv
- Official source
- Agency forecast source
- Last verified
- 2026-08-31